- Home
- KIDS vs IPSC Comparison
KIDS vs IPSC Comparison
Compare KIDS & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIDS | IPSC |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 464.9M | 441.9M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KIDS | IPSC |
|---|---|---|
| Price | $18.87 | $2.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | ★ $24.67 | $4.25 |
| AVG Volume (30 Days) | 100.9K | ★ 887.8K |
| Earning Date | 04-30-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.30 |
| EPS | N/A | ★ N/A |
| Revenue | $98,049,000.00 | ★ $109,164,000.00 |
| Revenue This Year | $14.07 | N/A |
| Revenue Next Year | $11.85 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 37.95 | ★ 1556.76 |
| 52 Week Low | $14.42 | $0.44 |
| 52 Week High | $23.70 | $2.97 |
Technical Indicators
Market Signals| Indicator | KIDS | IPSC |
|---|---|---|
| Relative Strength Index (RSI) | 61.24 | 51.78 |
| Support Level | $15.43 | $2.13 |
| Resistance Level | $18.94 | $2.45 |
| Average True Range (ATR) | 0.76 | 0.16 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 99.20 | 54.13 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.